Therapeutic Challenges in Chronic Spontaneous Urticaria
-
Published:2022-06-01
Issue:3
Volume:7
Page:283-286
-
ISSN:2149-7893
-
Container-title:Cyprus Journal of Medical Sciences
-
language:
-
Short-container-title:cjms
Publisher
Galenos Yayinevi
Reference20 articles.
1. A GA²LEN task force report;Maurer;Allergy,2011
2. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis;Guillén-Aguinaga;Br J Dermatol,2016
3. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria;Zuberbier;Allergy,2018
4. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study;Bérard;Br J Dermatol,2019
5. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects;Arm;Clin Exp Allergy,2014